H. Ni

发表

Use of Pralsetinib as Neoadjuvant Therapy for Non-Small Cell Lung Cancer Patient With RET Rearrangement

N. Zhou, Tong Li, Maoli Liang, 2022, Frontiers in Oncology.

Sorafenib Combined with Cryoablation to Treat Unresectable Hepatocellular Carcinoma

Ti Zhang, H. Ni, Zhi Guo, 2011, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

with chemotherapy in treating recurrent ovarian cancer

H. Ni, Zhi Guo, Weihao Zhang, 2015 .

Selective internal iliac artery oxaliplatin infusion: Another facultative treatment to unremitting hematuria in stage T4 bladder carcinoma

H. Ni, Zhi Guo, W. Xing, 2010 .

Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer

Ping Liu, Yan Xu, H. Ni, 2015, Cancer Chemotherapy and Pharmacology.

MDM2 sensitizes a human ovarian cancer cell line.

H. Ni, Ruo-Ran Mi, Hong Ni, 2003, Gynecologic oncology.

Lymph Node Metastases in Surgically Resected Solitary Ground-Glass Opacities: A Two-Center Retrospective Cohort Study and Pooled Literature Analysis

Liang Chen, Jun Chen, F. Ren, 2023, Annals of Surgical Oncology.

CT-guided 125I interstitial brachytherapy for pelvic recurrent cervical carcinoma after radiotherapy

Ping Liu, H. Ni, Zhi Guo, 2017, OncoTargets and therapy.

Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients

Ping Liu, Yan Xu, H. Ni, 2015, Cancer Chemotherapy and Pharmacology.

Ping Liu, H. Ni, Zhi Guo, 2014, International Journal of Gynecologic Cancer.

CT-guided 125I brachytherapy for recurrent ovarian cancer

Ping Liu, H. Ni, Zhi Guo, 2017, Oncotarget.